3 Year Absolute Returns
79.31% ↑
NAV (₹) on 15 Sep 2026
37.19
1 Day NAV Change
-1.79%
Risk Level
Very High Risk
Rating
-
LIC MF Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by LIC Mutual Fund Asset Management Limited. Launched on 08 Feb 2019, investors can start with a minimum ... Read more
AUM
₹ 103.11 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 63.69% |
| Hospitals & Medical Services | 29.16% |
| Chemicals - Others | 5.65% |
| Treps/Reverse Repo | 1.58% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.09% | ₹ 10.41 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 9.29% | ₹ 9.58 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 6.45% | ₹ 6.65 | Pharmaceuticals |
| Neuland Laboratories Ltd. | 6.38% | ₹ 6.58 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 6.23% | ₹ 6.42 | Hospitals & Medical Services |
| Navin Fluorine International Ltd. | 5.65% | ₹ 5.83 | Chemicals - Others |
| Aurobindo Pharma Ltd. | 5.17% | ₹ 5.33 | Pharmaceuticals |
| Aster DM Quality Care Ltd. | 4.82% | ₹ 4.97 | Hospitals & Medical Services |
| Zydus Lifesciences Ltd. | 4.79% | ₹ 4.94 | Pharmaceuticals |
| Gland Pharma Ltd. | 3.93% | ₹ 4.05 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 3.78% | ₹ 3.90 | Hospitals & Medical Services |
| Global Health Ltd. | 3.19% | ₹ 3.29 | Hospitals & Medical Services |
| IPCA Laboratories Ltd. | 3.18% | ₹ 3.28 | Pharmaceuticals |
| Metropolis Healthcare Ltd. | 3.17% | ₹ 3.27 | Hospitals & Medical Services |
| Cohance Lifesciences Ltd. | 2.92% | ₹ 3.01 | Pharmaceuticals |
| Mankind Pharma Ltd. | 2.89% | ₹ 2.98 | Pharmaceuticals |
| Artemis Medicare Services Ltd. | 2.88% | ₹ 2.97 | Hospitals & Medical Services |
| Glenmark Pharmaceuticals Ltd. | 2.88% | ₹ 2.97 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 2.55% | ₹ 2.63 | Hospitals & Medical Services |
| Dr Agarwal's Health Care Ltd. | 2.54% | ₹ 2.62 | Hospitals & Medical Services |
| Biocon Ltd. | 2.54% | ₹ 2.62 | Pharmaceuticals |
| Onesource Specialty Pharma Ltd. | 2.21% | ₹ 2.28 | Pharmaceuticals |
| Treps | 1.58% | ₹ 1.63 | Others |
| Syngene International Ltd. | 0.97% | ₹ 1 | Pharmaceuticals |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 15.91% | 14.45% | 7.23% | 21.49% |
| Category returns | 3.34% | 3.85% | 2.63% | 19.22% |
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29 | 18.43% | 142.90% | 0.00% | ₹11,478 | 1.78% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
LIC MF Gold ETF
ETF
Regular
|
₹134.62 | 36.49% | 148.72% | 208.78% | ₹1,500 | 0.45% |
High
|
|
LIC MF Gold ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹40.51 | 34.06% | 145.99% | 202.34% | ₹858 | 0.35% |
High
|
|
LIC MF Gold ETF FOF
Fund of Funds
Regular
|
₹38.29 | 33.67% | 143.22% | 196.50% | ₹858 | 0.61% |
High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹61.51 | 7.23% | 84.21% | 156.64% | ₹1,174 | 1.35% |
Very High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹60.39 | 7.22% | 84.08% | 155.54% | ₹1,174 | 1.35% |
Very High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹60.39 | 7.22% | 84.08% | 155.54% | ₹1,174 | 1.35% |
Very High
|
|
LIC MF Healthcare Fund - Direct Plan
Sector
Direct
|
₹37.18 | 14.44% | 79.25% | 76.61% | ₹103 | 1.42% |
Very High
|
|
LIC MF Healthcare Fund - Direct Plan
Sector
Direct
|
₹37.18 | 14.44% | 79.25% | 76.61% | ₹103 | 1.42% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹52.97 | 5.80% | 77.10% | 141.19% | ₹1,174 | 2.69% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹52.97 | 5.80% | 77.10% | 141.19% | ₹1,174 | 2.69% |
Very High
|
What is the current NAV of LIC MF Healthcare Fund - Direct Plan Growth?
What is the fund size (AUM) of LIC MF Healthcare Fund - Direct Plan Growth?
What are the historical returns of LIC MF Healthcare Fund - Direct Plan Growth?
What is the risk level of LIC MF Healthcare Fund - Direct Plan Growth?
What is the minimum investment amount for LIC MF Healthcare Fund - Direct Plan Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article